The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP 2C19 genotype
Abstract
Summary: Background: Acid inhibitory effects of proton pump inhibitors (PPI s) are influenced by CYP 2C19 genotype. In contrast, the potent acid inhibition of vonoprazan is not influenced by CYP 2C19 genotype. Aim: To compare the acid inhibitory effects of vonoprazan and esomeprazole in relation to CYP 2C19 genotype. Methods: Twenty‐eight healthy Japanese volunteers [7 CYP 2C19 poor metabolisers (PM s), 11 intermediate metabolisers (IM s) and 10 rapid metabolisers (RM s)] received four different regimens in a randomised crossover manner: (i) vonoprazan 20 mg twice daily (b.d.), (ii) vonoprazan 20 mg daily, (iii) esomeprazole 20 mg b.d. and (iv) esomeprazole 20 mg daily. The timing of each dosing was 1 h before a meal. Twenty‐four‐hour intragastric pH monitoring was performed on day 7 on each regimen. Results: In the overall genotype group,pH≥4 holding time ratios (pH 4 HTR s) with vonoprazan b.d., vonoprazan daily, esomeprazole b.d. and esomeprazole daily were 100%, 95%, 91%, and 68% respectively.pH 5 HTR s were 99%, 91%, 84% and 54% respectively. Vonoprazan b.d. potently suppressed acid for 24 h, and was significantly superior to other regimens irrespective of CYP 2C19 genotype. Vonoprazan daily was equivalent to esomeprazole b.d. in IM s and PM s, but superior in RM s.CYP 2C19 genotype‐dependent differences were observed in esomeprazole daily but not in vonoprazan b.d. or daily. Conclusion: Vonoprazan 20 mg b.d. inhibits acid irrespective of CYP 2C19 genotype, more potently than esomeprazole 20 mg b.d.,pH 4 and 5 holding time ratios reached 100% and 99%, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lundell, L., Vieth, M., Gibson, F., Nagy, P., & Kahrilas, P. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13324 · Cited by 258
Cited by
The Physiology of the Gastric Parietal Cell
Engevik, A. C., Kaji, I., & Goldenring, J. R. (2020) · Physiological Reviews · doi:10.1152/physrev.00016.2019 · Cited by 302
Fallone, C. A., Moss, S. F., & Malfertheiner, P. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.011 · Cited by 286
Physiologic, pathophysiologic, and pharmacologic regulation of gastric acid secretion
Schubert, M. L. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000392 · Cited by 99
Metadata
- Authors
- Kagami, T., Sahara, S., Ichikawa, H., Uotani, T., Yamade, M., Sugimoto, M., Hamaya, Y., Iwaizumi, M., Osawa, S., Sugimoto, K., Miyajima, H., & Furuta, T.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2016-03-18
- Volume
- 43
- Issue
- 10
- Pages
- 1048-1059
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2301012193
- Cited by
- 252
- References
- 1
- FWCI
- 25.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP 2C19 genotype. https://app.cochat.ai/papers/10.1111/apt.13588
- The paper
- Kagami, T., Sahara, S., Ichikawa, H., Uotani, T., Yamade, M., Sugimoto, M., Hamaya, Y., Iwaizumi, M., Osawa, S., Sugimoto, K., Miyajima, H., & Furuta, T. (2016). Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP 2C19 genotype. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.13588
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.